February 6th 2023
Findings from a phase 2/3 trial found better disease-free and overall survival outcomes with radiation plus docetaxel vs radiation alone in head and neck squamous cell carcinoma.
Locoregional Treatments Still Key in HCC Care
May 11th 2020A number of treatment options exist for patients with localized hepatocellular carcinoma (HCC), including surgical resection, transplantation, ablation, stereotactic body radiotherapy (SBRT), and embolization, said Riad Salem, MD, who added that a multidisciplinary team is needed to determine the optimal use of these approaches among newer novel systemic treatments.
Stereotactic Radiotherapy Device Approved by FDA to Treat Early Stage Breast Cancer
December 27th 2017The FDA has approved a novel breast-specific stereotactic body radiotherapy (SBRT) device known as GammaPod as a treatment for patients with early breast cancer, based on findings from a 17-patient study.
Complete Responses With Reduced-Dose Radiation in HPV-Linked Oropharynx Cancers
January 10th 2017For patients with HPV-related oropharyngeal squamous cell carcinoma, induction chemotherapy plus reduced-dose radiation and weekly cetuximab brought improvements for swallowing and nutritional status along with complete clinical responses.
Abdominal Radiation May Increase Diabetes Risk in Childhood Cancer Survivors
January 20th 2016Previous studies have linked radiation to the pancreas during childhood to an increased risk of type 1 or 2 diabetes, and in a recent small study, researchers investigated the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers.
For Patients With Inoperable Stage I NSCLC, Race, Hospital, and Insurance Status Matter
December 2nd 2014Despite the proven benefits of SBRT for patients with inoperable stage I NSCLC, whether such patients are offered it depends on their race, insurance status, and the type of facility where they are being treated.